MedTrace Logo

Plethysmographic Variability Index in Post Spinal Anesthesia Hypotension in Cesarean Section

NCT04010318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-03-26

No results posted yet for this study

Summary

* Full term pregnant female patients presented for elective C.S for single viable fetus will be included in this study.
* Before anesthesia, the patient will be attached to a monitor of: ECG , heart rate, non invasive blood pressure, pulse taximeter applied on the index finger of the limb not attached to the blood pressure cuff, pulse oximetry and plethysmographic variability index (PVI) and perfusion index (PI) will be taken by (Massimo radical 7, Massimo corp. USA). Measures will be recorded every 5 minutes preoperative.
* Patients with PVI \<15 will be excluded from the study.
* Patients with PVI \> 15 are started on intravenous infusion of warm ringer lactate solution via suitable pore intravenous cannula to reach target of PVI \<15 or a total 1 liter of ringer lactate.
* The patients in which the PVI is corrected by fluid to level below 15 will be Group (C) or corrected group. Patients in which intravenous fluid administration did not result any change in PVI or changed but still higher than 15 will be Group (NC) or non corrected group.

After preoperative preparation patient is shifted to operating theater, with all monitors applied. She will receive spinal block at lumbar 3-4 space with hyperbaric bupivacaine 8 mg plus 25 mic fentanyl. After giving anesthesia and positioning for surgery with a left lateral tilt of 15 degrees,

Conditions

  • Complication of Anaesthesia During Labour and Delivery

Interventions

PROCEDURE

Spinal Anesthesia

The patients will receive spinal block at lumbar 3-4 space with hyperbaric bupivacaine 8 mg plus 25 mic fentanyl. After giving anesthesia and positioning for surgery with a left lateral tilt of 15 degrees, supplemental oxygen at rate of 4 liter/minute is applied.

Sponsors & Collaborators

  • Tamer Mohamed Naguib

    collaborator UNKNOWN

  • Amr Ahmed Magdy

    collaborator UNKNOWN

  • Tanta University

    lead OTHER

Principal Investigators

  • Sameh Ismaiel, M.D · Lecturer of Anesthesia and Intensive Care, Tanta University

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-15
Primary Completion
2021-02-11
Completion
2021-02-11

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010318 on ClinicalTrials.gov